Predictive parameters of symptomatic radiation pneumonitis following stereotactic or hypofractionated radiotherapy delivered using volumetric modulated arcs

Radiotherapy and Oncology

Volumn 109, Issue 1, 2013, Pages 95-99

  Bongers, Eva M ^a   Botticella, Angela ^b   Palma, David A ^c   Haasbeek, Cornelis J A ^a   Warner, Andrew ^c   Verbakel, Wilko F A R ^a   Slotman, Ben ^a   Ricardi, Umberto ^b   Senan, Suresh ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Lung tumors; Radiation pneumonitis; Stereotactic radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BRONCHUS OBSTRUCTION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CONTROLLED STUDY; DOSIMETRY; FEMALE; HUMAN; HYPOFRACTIONATED RADIOTHERAPY; LUNG EMBOLISM; LUNG HEMORRHAGE; LUNG LOBECTOMY; LUNG RESECTION; LUNG TUMOR; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PLEURISY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE FRACTIONATION; RADIATION PNEUMONIA; RADIOTHERAPY EQUIPMENT; STEREOTACTIC ABLATIVE RADIOTHERAPY; STEREOTACTIC BODY RADIATION THERAPY; THORAX PAIN; TREATMENT PLANNING; TUMOR VOLUME; VOLUMETRIC ARC THERAPY;

LUNG TUMORS; RADIATION PNEUMONITIS; STEREOTACTIC RADIOTHERAPY;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIATION PNEUMONITIS; RADIOSURGERY; RADIOTHERAPY, INTENSITY-MODULATED; TUMOR BURDEN;

EID: 84888068730     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.10.011     Document Type: Article

References (20)

1. D.A. Palma, and S. Senan Early-stage non-small cell lung cancer in elderly patients: should stereotactic radiation therapy be the standard of care? Int J Radiat Oncol Biol Phys 84 2012 1058 1059
2. N.E. Verstegen, J.W. Oosterhuis, and D.A. Palma Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis Ann Oncol 85 2013 190 195
3. R. Baker, G. Han, and S. Sarangkasiri Clinical and dosimetric predictors of radiation pneumonitis in a large series of patients treated with stereotactic body radiation therapy to the lung Int J Radiat Oncol Biol Phys 85 2013 190 195
4. M. Guckenberger, K. Baier, and B. Polat Dose-response relationship for radiation-induced pneumonitis after pulmonary stereotactic body radiotherapy Radiother Oncol 97 2010 65 70
5. G.R. Borst, M. Ishikawa, and J. Nijkamp Radiation pneumonitis in patients treated for malignant pulmonary lesions with hypofractionated radiation therapy Radiother Oncol 91 2009 307 313
6. J.Y. Chang, H. Liu, and P. Balter Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer Radiat Oncol 7 2012 152
7. U. Ricardi, A.R. Filippi, and A. Guarneri Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy Acta Oncol 48 2009 571 577
8. S. Senthi, C.J. Haasbeek, B.J. Slotman, and S. Senan Outcomes of stereotactic ablative radiotherapy for central lung tumours: a systematic review Radiother Oncol 106 2013 276 281
9. C.L. Ong, D. Palma, W.F. Verbakel, B.J. Slotman, and S. Senan Treatment of large stage I-II lung tumors using stereotactic body radiotherapy (SBRT): planning considerations and early toxicity Radiother Oncol 97 2010 431 436
10. E.M. Bongers, M.R. Dahele, and C.J. Haasbeek Hypofractionated stereotactic radiation therapy for large and central lung tumors Int J Radiat Oncol Biol Phys 84 2012 S449 S550 [Abstract]
11. F.J. Lagerwaard, N.E. Verstegen, and C.J. Haasbeek Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer Int J Radiat Oncol Biol Phys 83 2012 348 353
12. W.F. Verbakel, S. Senan, J.P. Cuijpers, B.J. Slotman, and F.J. Lagerwaard Rapid delivery of stereotactic radiotherapy for peripheral lung tumors using volumetric intensity-modulated arcs Radiother Oncol 93 2009 122 124
13. J.F. Fowler 21 years of biologically effective dose Br J Radiol 83 2010 554 568
14. R.B. Barriger, J.A. Forquer, and J.G. Brabham A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy Int J Radiat Oncol Biol Phys 82 2012 457 462
15. Y. Matsuo, K. Shibuya, and M. Nakamura Dose-volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer Int J Radiat Oncol Biol Phys 83 2012 e545 e549
16. A. Takeda, T. Ohashi, and E. Kunieda Comparison of clinical, tumour-related and dosimetric factors in grade 0-1, grade 2 and grade 3 radiation pneumonitis after stereotactic body radiotherapy for lung tumours Br J Radiol 85 2012 636 642
17. M.C. Stauder, O.K. Macdonald, and K.R. Olivier Early pulmonary toxicity following lung stereotactic body radiation therapy delivered in consecutive daily fractions Radiother Oncol 99 2011 166 171
18. H.F. Van den, G. Defraene, W. Crijns, and R. Bogaerts Out-of-field contributions for IMRT and volumetric modulated arc therapy measured using gafchromic films and compared to calculations using a superposition/convolution based treatment planning system Radiother Oncol 105 2012 127 132
19. C. Ludwig, E. Stoelben, M. Olschewski, and J. Hasse Comparison of morbidity, 30-day mortality, and long-term survival after pneumonectomy and sleeve lobectomy for non-small cell lung carcinoma Ann Thorac Surg 79 2005 968 973
20. J.R. van Sornsen de Koste, M. Dahele, and H. Mostafavi Digital tomosynthesis (DTS) for verification of target position in early stage lung cancer patients Med Phys 40 2013 091904